Here are some of the biggest movers of the day: Novovax Inc. NVAX shares jumped 3% after the U.S. pharma firm’s new COVID vaccine gained approval in the…
A realty deal between the US government and the Poonawallas was struck in 2015, when the property was sold at Rs 750 cr, but they have not been able to take control of the property.
CEO of Serum Institute of India, Adar Poonawalla stated that their Covovax vaccine will be approved as a COVID-19 Booster dose in the next 10 to 15 days. He further said that the vaccine is highly effective against the Omicron variants of coronavirus. Covovax is the indigenous version of a Covid vaccine developed by Novovax